Dr Audrey Coilly obtained her medical degree in 2009. She has been a Fellow since 2009, at the Centre Hepato-Biliaire, Paul Brousse hospital, Villejuif, France. Her clinical areas of expertise include hepatology, liver transplantation, and specifically the use of new direct antiviral agents (DAA) after liver transplantation in a context of HCV recurrence. Dr Coilly is currently a PhD student and her current research interests include lipidomic analysis and lipotoxicity in NASH. Starting last year, she has been coordinating a European multicentric study concerning the use of DAA after liver transplantation (CUPILT), within the National Research Network in HIV and Viral Hepatitis (ANRS).